1. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol Off J Am Soc Clin Oncol,1992
2. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol Off J Am Soc Clin Oncol,2000
3. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours;Sternberg;Eur J Cancer Oxf Engl 1990,2006
4. Cancer of the Urinary Bladder - Cancer Stat Facts. SEER. Accessed: March 19, 2024. https://seer.cancer.gov/statfacts/html/urinb.html
5. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a retrospective international study of invasive/advanced cancer of the urothelium (RISC);Bamias;Ann Oncol Off J Eur Soc Med Oncol,2018